Versigent (NYSE:VGNT) Upgraded at The Goldman Sachs Group

Versigent (NYSE:VGNT) was upgraded by equities researchers at The Goldman Sachs Group to a “strong-buy” rating in a research note issued on Monday,Zacks.com reports.

Several other research analysts have also recently weighed in on the stock. Wolfe Research started coverage on shares of Versigent in a report on Thursday, April 30th. They issued an “outperform” rating and a $53.00 price target for the company. Fox Advisors raised shares of Versigent to a “strong-buy” rating in a research report on Tuesday, April 7th. Wall Street Zen upgraded shares of Versigent to a “hold” rating in a report on Saturday, April 18th. UBS Group cut their price objective on shares of Versigent from $58.00 to $55.00 and set a “buy” rating on the stock in a research report on Thursday, July 9th. Finally, Wells Fargo & Company upped their target price on shares of Versigent from $42.00 to $48.00 and gave the stock an “overweight” rating in a research note on Thursday, June 25th. Three equities research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $49.60.

Versigent Price Performance

NYSE VGNT opened at $39.97 on Monday. The business’s 50 day simple moving average is $43.46. Versigent has a 52-week low of $26.34 and a 52-week high of $50.88.